Brenus Pharma graduates from the Creative Destruction Lab’s 2023/2024 global cancer stream, in partnership with north American universities
#AACR2024 Brenus Pharma unveils promising and robust pre-clinical efficacy extrapolating human conditions with STC-1010
France Biotech unveils the winners of the 2024 edition of the “HealthTech Trophies”: Spotlight on 9 innovative healthcare companies!
Brenus Pharma, winner of the call for proposals “Innovations in biotherapies and bioproduction for France 2030”, receives €5 Million for its anticancer immunotherapy
Brenus Pharma joins the Paris Saclay Cancer Cluster (PSCC) to collaborate at the heart of innovation in oncology
Brenus Pharma unveils promising pre-clinical results extrapolating human conditions in major international congresses
